Fresenius Kabi
The Manager, Corporate Portfolio and M&A plays a key role in managing and growing Fresenius' corporate portfolio through organic and inorganic strategic projects, new business development, and venture investments. This visible position involves regular interaction with Fresenius' management teams and requires analyzing markets to identify targets for inorganic growth, particularly in nutrition, MedTech, and biopharmaceuticals. The role focuses on project management, due diligence, business case development, and executing strategic corporate projects.
Headquarters
Lake Zurich, Illinois, United States
Company Size
1001-5000 employees
Founded
1912
Fresenius Kabi is a global healthcare company committed to transforming historic breakthroughs in science and healthcare into accessible medicines and technologies. The company offers a broad portfolio spanning pharmaceuticals (including injectable drugs), biopharmaceuticals, parenteral nutrition, and medical technologies such as infusion systems, apheresis devices, and cell and gene therapy instruments. Fresenius Kabi serves hospitals, blood centers, and patients across the U.S. and worldwide, with a mission centered on expanding access, safety, and efficiency in healthcare.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Fresenius Kabi.